4//SEC Filing
Misfeldt Dayton 4
Accession 0000899243-19-018931
CIK 0001061027other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 5:31 PM ET
Size
8.0 KB
Accession
0000899243-19-018931
Insider Transaction Report
Form 4
Misfeldt Dayton
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2019-06-28+480,000→ 480,000 totalExercise: $0.73Exp: 2029-06-28→ Common Stock (480,000 underlying) - Award
Stock Option (Right to Buy)
2019-06-28+60,000→ 60,000 totalExercise: $0.73Exp: 2029-06-28→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date.
- [F2]The option vests monthly over six (6) months from the date of grant subject to the optionee's continued service to the Company.
Documents
Issuer
SUNESIS PHARMACEUTICALS INC
CIK 0001061027
Entity typeother
Related Parties
1- filerCIK 0001461466
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 5:31 PM ET
- Size
- 8.0 KB